United Cannabis Corp
Healthcare · Pharmaceutical Preparations · CO · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annual| FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | |
|---|---|---|---|---|---|---|
| Revenue | $7.2M | $362,323 | $715,095 | $562,673 | $186,557 | $105,662 |
| Operating income | −$21.3M | −$5.2M | −$767,022 | −$1.4M | −$1.8M | −$33,661 |
| Net income | −$24.1M | −$5.9M | −$3.9M | −$2.9M | −$2.5M | −$3,165 |
| Total assets | $12.9M | $7.1M | $284,153 | $594,428 | $1.3M | $58,892 |
| Total liabilities | $5.6M | $1.2M | $760,812 | $3.1M | $2.3M | $50,000 |
| Equity | $7.6M | $5.9M | −$476,659 | −$2.5M | −$997,999 | $8,892 |
| EPS (diluted) | — | — | — | — | — | — |
| Shares out. | 64.1M | 50.7M | 45.0M | 44.7M | 1.5M | 1.5M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2018- Operating margin
- −293.3%
- Net margin
- −332.7%
- Return on equity
- −318.5%
- Return on assets
- −187.0%
- Return on capital (ROCE)
- −291.0%
- Liabilities / assets
- 43.4%
- Debt / equity
- 0.74×
- Book value / share
- $0.12
- Revenue growth (YoY)
- 1899.5%
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2018- Altman Z″ (distress)
- -20.67distress
- Accruals / assets
- −130.7%clean
- Piotroski F-Score
- 3/9weak
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast. What these scores mean →
Signs
● 2 severe● 3 warning● 3 good- Altman Z″ in the distress zone
- Filed a late-filing notice (Form NT) — missed an SEC deadline
- Operating losses (negative operating margin)
- Reported a net loss
- Negative operating cash flow
- Revenue is growing year-over-year
- Conservative leverage (liabilities < 50% of assets)
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-Kmissed a reporting deadline ↗Mar 30, 2020
- NT 10-Qmissed a reporting deadline ↗May 15, 2019
- NT 10-Qmissed a reporting deadline ↗Nov 15, 2017
- NT 10-Qmissed a reporting deadline ↗Nov 14, 2016
- NT 10-Qmissed a reporting deadline ↗Aug 12, 2016
- NT 10-Qmissed a reporting deadline ↗May 13, 2016
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
Insider transactions
SEC Form 4 · most recent| Insider | Date | Type | Shares | Price |
|---|---|---|---|---|
| Verzura Tony10% owner | Aug 29, 2019 | Sell | 925,000 | $0.25 |
| Verzura Tony10% owner | Aug 21, 2019 | Sell | 2.8M | $0.25 |
| Verzura Tony10% owner | Jul 31, 2019 | Sell | 106,000 | $0.49 |
| Verzura Tony10% owner | Jul 26, 2019 | Sell | 80,000 | $0.51 |
| Verzura Tony10% owner | Jun 26, 2019 | Sell | 2.8M | $0.25 |
| Verzura Tony10% owner | May 14, 2019 | Sell | 200,000 | $0.25 |
| Verzura Tony10% owner | Mar 29, 2019 | Sell | 1,500 | $0.35 |
| Verzura Tony10% owner | Mar 28, 2019 | Sell | 500 | $0.36 |
| Verzura TonyOfficer — Vice President | Mar 18, 2019 | Sell | 254 | $0.40 |
| Verzura TonyOfficer — Vice President | Mar 15, 2019 | Sell | 2,500 | $0.41 |
| Verzura TonyOfficer — Vice President | Jul 19, 2018 | Sell | 35,654 | $0.78 |
Headline trade per Form 4 (officers, directors, 10%+ owners). Buy/sell read from the filing's structured data — blank where a field isn't cleanly tagged.
Material events
SEC Form 8-K · most recent- Director / officer changeJul 21, 2020
- Bankruptcy or receivership · Debt acceleration / triggering eventApr 24, 2020
- Unregistered equity saleJan 10, 2020
- Other material eventOct 22, 2019
- Entered a material agreementJul 16, 2019
- Entered a material agreementJun 27, 2019
- Entered a material agreement · New financial obligation · Unregistered equity saleJun 24, 2019
- Shareholder voteMay 23, 2019
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- REVOKEDFeb 2, 2022
- 8-KFORM 8-K RUBY RESIG. 7-20Jul 21, 2020
- SC 13GJun 30, 2020
- 8-KCURRENT REPORTApr 24, 2020
- NT 10-K12B FOR DEC 2019 10-KMar 30, 2020
- SC 13G/AAMENDMENT TO SCHEDULE 13GFeb 14, 2020
- 8-K8-K ISSUE HART 300K SHARESJan 10, 2020
- 10-QQUARTERLY REPORTNov 14, 2019
- 8-KCURRENT REPORTOct 22, 2019
- 5PRIMARY DOCUMENTAug 30, 2019
- 4PRIMARY DOCUMENTAug 30, 2019
- 4PRIMARY DOCUMENTAug 23, 2019
- 10-QQUARTERLY REPORTAug 14, 2019
- 4PRIMARY DOCUMENTAug 5, 2019
- 4PRIMARY DOCUMENTJul 31, 2019
Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.